Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today announced positive topline results of RA-BEAM, the fourth ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA Management Comments

Lilly's (LLY) Risk/Reward Looks Good Ahead of Q3 Report - BMOOctober 16, 2015 10:45 AM Eli Lilly & Co. (LLY), Boehringer Announces U.S. Availability of Synjardy TabsOctober 14, 2015 8:31 AM Baricitinib Demonstrates Superiority to Adalimumab in Improving Signs and Symptoms of Rheumatoid Arthritis in Pivotal Phase 3 StudyOctober 14, 2015 6:45 AM